Lowey Dannenberg Notifies Pacira Biosciences, Inc. (“Pacira” or the “Company”) (NASDAQ: PCRX) Investors of Securities Class Action Lawsuit and Encourages Investors with more than $100,000 in Losses to Contact the Firm

GlobeNewswire
2025.02.07 18:39

Lowey Dannenberg P.C. has filed a class action lawsuit against Pacira Biosciences, Inc. (NASDAQ: PCRX) for violations of federal securities laws on behalf of investors who purchased shares between August 2, 2023, and August 8, 2024. The lawsuit alleges that Pacira misled investors regarding patent protections for its product Exparel, which constitutes about 80% of its revenue. Investors who suffered losses exceeding $100,000 are encouraged to contact the firm before March 14, 2025, to participate in the lawsuit.

Source: GlobeNewswire The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.